Trial Details

UNKNOWN
Basic Information
Clinical ID c463
Identifier NCT03669029
Trial Title Optimization of Golimumab Treatment in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colitis, Ulcerative
Interventions DRUG: Golimumab 50 mg in patients 80 kg|DRUG: Golimumab treatment optimization.
Participant Information
Sponsor Hospital de Manises
City Manises
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2018-10-01
Primary Completion Date 2019-12-31
Completion Date 2019-12-31